A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

NCT06097975 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DRUG: Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
PROCEDURE: Neurosurgery and intracavitary injection nivolumab and ipililumab
DRUG: Adjuvant nivolumab IV + nivolumab and ipililumab intracavitary

Sponsor

Universitair Ziekenhuis Brussel